| Emerging functions of the EGFR in cancer |
127 |
| The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment |
62 |
| Involvement of the long noncoding RNA NEAT1 in carcinogenesis |
40 |
| Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer |
35 |
| Early-onset colorectal cancer in young individuals |
35 |
| Long noncoding RNAs as regulators of cancer immunity |
24 |
| Circular RNA profiling identifies circADAMTS13 as a miR-484 sponge which suppresses cell proliferation in hepatocellular carcinoma |
23 |
| Exosomal microRNAs as tumor markers in epithelial ovarian cancer |
21 |
| Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA |
21 |
| Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition |
20 |
| New clinical trial designs in the era of precision medicine |
20 |
| Long non-coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1 |
20 |
| Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states |
18 |
| Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer |
17 |
| Hypoxia-driven paracrine osteopontin/integrin alpha v beta 3 signaling promotes pancreatic cancer cell epithelial-mesenchymal transition and cancer stem cell-like properties by modulating forkhead box protein M1 |
16 |
| High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification |
16 |
| Identification of lncRNAs associated with early-stage breast cancer and their prognostic implications |
16 |
| Exploiting DNA repair defects in colorectal cancer |
16 |
| A patient-derived explant (PDE) model of hormone-dependent cancer |
16 |
| Intratumor heterogeneity defines treatment-resistant HER2+breast tumors |
16 |
| Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancer |
16 |
| Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients |
15 |
| Cancer survivorship: an integral part of Europe's research agenda |
15 |
| Long noncoding RNA ZNF667-AS1 reduces tumor invasion and metastasis in cervical cancer by counteracting microRNA-93-3p-dependent PEG3 downregulation |
15 |
| TGF-beta transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways |
15 |
| Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions |
14 |
| Down-regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA-145-mediated inhibition of FSCN1 |
14 |
| Intricate crosstalk between MYC and non-coding RNAs regulates hallmarks of cancer |
14 |
| Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma |
13 |
| Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer |
13 |
| p53-independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell carcinoma cells |
13 |
| ANP32E induces tumorigenesis of triple-negative breast cancer cells by upregulating E2F1 |
13 |
| TRPM4 regulates Akt/GSK3-beta activity and enhances beta-catenin signaling and cell proliferation in prostate cancer cells |
13 |
| Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma |
13 |
| SIRT5-mediated deacetylation of LDHB promotes autophagy and tumorigenesis in colorectal cancer |
12 |
| Cancer Prevention Europe |
12 |
| Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death |
12 |
| miR-372 and miR-373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways |
12 |
| Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition |
12 |
| miR-181a/b therapy in lung cancer: reality or myth? |
11 |
| Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2-and CXCL8-mediated cancer cell migration |
11 |
| ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin-1-dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone |
11 |
| Hypoxia-sensitive LINC01436 is regulated by E2F6 and acts as an oncogene by targeting miR-30a-3p in non-small cell lung cancer |
11 |
| Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment |
11 |
| Specific breast cancer prognosis-subtype distinctions based on DNA methylation patterns |
10 |
| Identification of tumor suppressor miRNAs by integrative miRNA and mRNA sequencing of matched tumor-normal samples in lung adenocarcinoma |
10 |
| Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer |
10 |
| Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon-independent manner |
10 |
| Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer |
10 |
| MiR-195 and miR-497 suppress tumorigenesis in lung cancer by inhibiting SMURF2-induced TGF-beta receptor I ubiquitination |
10 |
